We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KYIV:NASDAQKyivstar Group Ltd. Analysis

Data as of 2026-06-11 - not real-time

$13.30

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Kyivstar Group Ltd. (KYIV) is trading at $13.30, far below its DCF fair value of $107.53, implying a potential upside of over 30% per the model. The company delivers robust fundamentals: revenue of $1.22 B grew 26.7% YoY, gross margin is an impressive 89.2%, and operating cash flow exceeds $590 M, supporting a strong balance sheet despite a debt-to-equity ratio of 39.2. Recent material news highlights the completion of a strategic acquisition and the appointment of a new CFO, signaling continued expansion and leadership depth. Technically, the stock sits above its 50‑day SMA ($12.64) and 200‑day SMA ($12.44) indicating a bullish trend, but it remains below the 20‑day SMA ($13.94) and the MACD histogram is negative, suggesting short‑term pressure. The RSI at 46 points to a neutral stance, while volume is decreasing, adding a note of caution. Overall, the blend of solid growth metrics, significant valuation upside, and a bullish medium‑term trend supports a positive outlook, though short‑term volatility and geopolitical exposure warrant a measured approach.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below 20‑day SMA and bearish MACD histogram
  • Decreasing volume trend
  • Neutral RSI indicating no strong momentum

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth and high margins
  • Strategic acquisition completed, expanding market footprint
  • Technical support from 50‑day and 200‑day SMAs and bullish trend direction

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Significant valuation upside versus DCF fair value
  • Robust cash generation and low dividend reliance
  • Positioning in Ukraine’s digital infrastructure with long‑term growth tailwinds

Key Metrics & Analysis

Financial Health

Revenue Growth26.70%
Profit Margin13.47%
P/E Ratio18.5
ROE13.30%
ROA12.80%
Debt/Equity39.22
P/B Ratio2.3
Op. Cash Flow$591.0M
Free Cash Flow$695.0M
Industry P/E16.9

Technical Analysis

TrendBullish
RSI46.4
Support$13.18
Resistance$14.79
MA 20$13.94
MA 50$12.64
MA 200$12.44
MACDBearish
VolumeDecreasing
Fear & Greed Index83.57

Valuation

Fair Value$107.53
Target Price$17.52
Upside/Downside31.69%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta1.48
Volatility39.67%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.